KEYNOTE SPEAKERS
Matthew R. Galeotti, JD
Head, Criminal Division, US Department of Justice; Author, DOJ Memorandum: Focus, Fairness, and Efficiency in the Fight Against White-Collar Crime, Washington, DC
Mary E. Riordan, JD
Senior Counsel to the Inspector General, Inspector General, US Department of Health and Human Services, Washington, DC
Amy L. Bedsaul
Open Payments Communications, Data Analytics & Systems Group, Centers for Medicare & Medicaid Services, Baltimore, MD
Veronika Peleshchuk Fradlin, MA
Director of Division of Transparency Projects, Centers for Medicare and Medicaid Services, Baltimore, MD
Charlene Keller Fullmer, JD
Assistant US Attorney and Deputy Chief Civil Division, US Attorney’s Office, Eastern District of Pennsylvania, US Department of Justice; Former Attorney Advisor, FBI, Philadelphia, PA
Abraham George, JD
Assistant US Attorney and Chief, Civil Division, US Attorney Office, District of Massachusetts, Boston, MA
Mackenzie Queenin, JD
Assistant US Attorney and Chief, Health Care Fraud, US Attorney Office, District of Massachusetts; Adjunct Professor, Boston College of Law, Boston, MA
FEATURED FACULTY
Andrew Blasi, MBA
Founder & CEO, Ethicist Intl; Founding Member, Anti-Corruption Leaders Hub, OECD; Faculty, Intl Anti-Corruption Academy, Washington, DC
Tess Carey, PharmD
Senior Pharmacist, Clinical Strategy, Amazon Pharmacy, Philadelphia, PA
Virginia MacSuibhne, JD
The Compliance Fairy Godmother; Executive Director, Legal Compliance, Alumis; Former VP & Global CCO, Agilent Technologies, Santa Clara, CA
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics &Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC
Spencer Stiles, MBA
Group President, Orthopaedics, Stryker; Director, Chart Industries; Director, Medical Device Manufacturers Association; Director, Business Leaders for Michigan, Kalamazoo, MI
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC
ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL
Aisha M. Ghazi Babar, LLB, LLM
General Counsel, Chief Compliance Officer & Corporate Secretary, Pierre Fabre; Former GC & CCO,, Navigate BioPharma Services, Secaucus, NJ
Rachel Batykefer
Vice President, CIA & Compliance Operations, Mallinckrodt; Former Sr. Director, Global Compliance & Ethics Training, Teva, Philadelphia, PA
Peter Brensilver, JD
Senior Vice President, Chief Global Commercial Compliance and Risk Counsel, Pfizer, New York, NY
Terra Buckley, JD
Chief Compliance Officer, LivaNova; Former VP & Head of Compliance, Mesoblast, Summit, NJ
Sri Burra, MBA
Director, US Ethics and Compliance, Organon; Former Ethics & Compliance Lead, North America, Haleon, Malvern, PA
Briana Cabrera, MS, CFE
Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL
Reanna Carver, JD
Assistant General Counsel, Accord BioPharma, Raleigh, NC
Shoshanna Clark, JD
Vice President, Ethics & Compliance, Kailera Therapeutics; Former Vice President, Chief Compliance Officer, Cerevel Therapeutics, Boston, MA
Steven Cohen, MBA
Vice President, Chief Ethics and Compliance Officer, North America, Eli Lilly, Fishers, IN
Tiffany Cummings-Damiani, JD
Vice President, Head of Ethics and Compliance, US, Amicus; Former President, Head of Global Compliance, Insmed, Philadelphia, PA
Thomas Daly, JD
Associate Director, Compliance, Biocon Biologics, Bridgewater, NJ
Brian Danahy, JD
Deputy General Counsel and Chief Compliance Officer, Exactech; Former, Compliance Program Manager, Zimmer, Gainesville, FL
Evan DaSilva, CPA, CFE, CAMS
US Business Ethics Monitoring & Operations, Ipsen Biopharmaceuticals, Boston, MA
David J. Derusha, JD
Compliance Director, Vertex Pharmaceuticals; Former Assistant US Attorney, US Attorney’s Office, District of Massachusetts, Boston, MA
Sarah diFrancesca, JD
Executive Director, Compliance Lead, Immunology & Dermatology, Incyte, Wilmington, DE
Edgar H. Donohoe, JD
Vice President & Lead Compliance Counsel, Pfizer US, New York, NY
Margaret K. Feltz, MA, JD
Vice President, Chief Compliance Officer, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CT
Jeanille Gatta, MA
Director, Compliance Business Partner, AstraZeneca, North America, Philadelphia, PA
Patrick Gibson, JD
Former Associate Vice President, Global Compliance Counseling, Organon; Former Special Assignment — Global Compliance Separation Lead, Merck, Villanova, PA
Kate Godfrey, JD, CCEP
Senior Vice President, Global Chief Compliance Officer, Karl Storz, US; Former VP, Chief Compliance and Privacy Officer, Veracyte, Inc., Seattle, WA
Asha Green, JD, MPA, CCEP, CHC
Director, US Compliance, Ferring; Former Global Head, I&C Risk Assessment & Mitigation Planning, Indivior, Parsippany NJ
Ayushman Hazarika, CA, MBA, CFE
Managed Markets Finance, Novartis; Former US SEC and Management Reporting, Merck and Schering-Plough, Berkeley Heights, NJ
Tom Hiney, JD, CIPP/US, CIPM
Privacy Counsel and Senior Director, Blueprint Medicines, Boston, MA
Peter Jensen, JD
Vice President, Global Chief Compliance Officer, Arthrex; Former Chief Nominations Counsel, US Senate Judiciary Committee, Naples, FL
Abe Kassis, PhD
Senior Director, Global Head Compliance and Legal Operations, Bausch + Lomb; Former Global Compliance – Director of Compliance, New York, NY
Joseph E. Keeney, JD
Former Head, Ethics and Compliance, Galderma Laboratories; Former Sr. Director/Head, Healthcare Compliance, Organogenesis, Dallas, TX
Jonathon L. Kellerman
Global Chief Ethics, Compliance and Privacy Officer & Global Head of Business Transformation, Bausch + Lomb; Former EVP & Global CCO, Allergan, Bridgewater, NJ
Sara Kimball, JD
Assistant General Counsel, Daiichi Sankyo, Basking Ridge, NJ
JJ Kuhn, JD
Senior Vice President Chief Ethics & Compliance Officer, Solventum; Former VP Chief Counsel, Global Investigations, Medtronic, St. Paul, MN
Angelique Lee, JD
Former Vice President, Chief Compliance and Ethics Officer, Jazz Pharmaceuticals; Former VP, Global CCO, Greenwich Biosciences, San Juan Capistrano, CA
Jeff Lemay, JD
Former Executive Director, N.A. Compliance Officer, Jazz; Former Sr. Director, US Compliance Officer, Greenwich Bioscience, Carlsbad, CA
Aaron Lewis, MBA
Director, Legal and Compliance Operations, Cordis; Former Director, Compliance Insights and Technologies, Cardinal Health, Columbus, OH
Jill Mason, JD
Chief Compliance and Risk Officer, Orthofix; Former Senior Global Compliance Director, St. Jude Medical, Dallas, TX
Jenny McVey, MS, PhD
Former North America Compliance Officer, bioMerieux; Adjunct Professor, Fordham University School of Law, Salt Lake City, UT
Kelley Medeiros, MPH
Compliance Officer, Neuromodulation; Compliance Officer, LivaNova; Former Global & US Oncology Compliance Officer, EMD Serono, Boston, MA
Lucy Muzzy, JD
Vice President Enterprise Lead Responsible AI, Digital and Privacy Compliance Counsel, Pfizer; Former Assistant US Attorney, US Attorney’s Office, New Jersey, New York, NY
Brooke Nelson, JD
Vice President, Ethics & Business Integrity, North America & Global Specialty Care, Sanofi; Former CCO, Verily; Former Executive Director, Compliance, Amgen, Los Angeles, CA
Meredith Odell
Executive Director Marketing, AstraZeneca; Former Specialty Sales Representative, GSK, Wilmington, DE
Nereida Parks, MBA, MPH, JD
Privacy, AI and HIPAA Officer, OAC, Olympus Medical; Former Regional Privacy Officer, North America and Specialty Care, Sanofi, Westborough, MA
Richard Perry, MEd
Compliance Operations Manager, Incyte; Board Member, William Way LGBT Community Center; Former Corporate Compliance Specialist, Adaptimmune, Wilmington, DE
Erica (Owen) Powers
Vice President, Chief Compliance Officer, Sage Therapeutics; Former Director Corporate Compliance, Vertex, Boston, MA
Omar Richardson, MBA
Senior Director of Compliance, Shionogi; Former Compliance Officer, Grünenthal; Former Director, Corporate Compliance, Indivior, New York, NY
Patrick Santiago, MBA, CIPM
Director, Global Data Privacy, Genmab; Former Associate Director, US Data Privacy Operations, Boehringer Ingelheim, Plainsboro, NJ
Monica Schroeter, CPA, CISA
Head of Compliance Operations and Risk, LivaNova; Former Head of Compliance, F2G, Summit, NJ
Elizabeth Smith, JD
Senior Director, G&A Contracts and Data Privacy, Exelixis; Former Head, Global Privacy & Associate GC, Seagen, Louisville, KY
Jeffrey Stark, MD
Vice President and Head of Medical Immunology, UCB, Smyrna, GA
Emily Treanor, JD
Head of Global Investigations and Enterprise Risk Management, Alnylam Pharmaceuticals, Washington, DC
Natasha Trifun, JD
Head, Enterprise Compliance & Risk and Privacy, AstraZeneca; Former Head, Ethics and Compliance for EUCAN/ International, R&D & Operations, Alexion AstraZeneca Rare Disease; Former Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA
Kelly J. Tope, JD, MBA
Head, Ethics and Business Integrity Governance, Operations & Risk Mgmt, Sanofi; Former Head, USBU Ethics & Compliance Monitoring & Reporting Operations, Takeda, Boston, MA
Sarah Whipple, JD
Vice President, Global Chief Compliance Officer, Apellis; Former VP, Legal & Chief Compliance Officer, Akebia; Former VP, Global Compliance & Privacy Officer, Aegerion, Boston, MA
Susan Williamson, MBA
Senior Vice President & Chief Compliance Officer, Endo; Former Senior Manager, WBB Finance, Operational Risk Management, Pfizer, Malvern, PA
Matt Zebley
Senior Manager, Compliance, Transparency and HCP Engagement, Incyte Corporation, Wilmington, DE
FORMER SENIOR GOVERNMENT OFFICIALS
Jennifer Bragg, JD
Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC
Greg Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US Department of Health and Human Services, Washington, DC
Jacob T. Elberg, JD
Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney’s Office, District of New Jersey, Newark, NJ
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Paul Joseph, JD
Senior Director, Counsel, Eli Lilly; Former Associate Chief Counsel for Enforcement, US FDA; Former Senior Trial Attorney, Criminal Division, US DOJ, Potomac, MD
John Kelly, JD
Partner and Chair, Healthcare Industry Practice, Barnes & Thornburg; Former Assistant Chief for Health Care Fraud, Criminal Division, Fraud Section, US Department of Justice, Washington, DC
Joshua S. Levy, JD
Partner, Ropes & Gray LLP; Former US Attorney for the District of Massachusetts, Boston, MA
Allan Medina, JD
Partner, Goodwin Procter; Former Senior Deputy Chief, Criminal Division, US Department of Justice, Washington, DC
Michael L. Shaw, JD
Global Head, Compliance, Privacy & Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ
